A group of about 30 people pose together in a bright office space.
Today, we’re launching a new company, ALTx Therapeutics. Founded by Simon Boulton, the company will develop the first precision therapies targeting ALT cancers, in partnership with Slingshot Therapeutics Limited and @crhorizons.bsky.social.
Find out more ➡️ www.crick.ac.uk/news/2026-02...